Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article libraryTriglycerides usually fall substantially, HDL nudges up, and LDL drops modestly. If LDL is the main concern, a statin remains first-line.
Yes — weight loss can pull blood sugar back to normal and may prevent progression to diabetes. Acting early, alongside lifestyle change, gives the best odds.
Occasionally fine, but routinely skipping meals can push intake too low, costing muscle and energy. Aim for small, protein-led meals even when not very hungry.
Either you're due a dose step-up, or weight loss has lowered your calorie needs and you've plateaued. Discuss adjusting the dose with your doctor.
The evidence to date is reassuring across multi-year trials, including cardiovascular benefit. Ongoing monitoring keeps it safe for long-term use.
Three litres of fluid, daily isabgol, fruit and sprouts, and a post-meal walk fix most cases within a week. A safe laxative helps if needed.
Usually, as a result of weight loss — often by 5–8 mmHg systolic over months. Your BP tablets may need reducing, so don't stop them on your own.
Yes — weight loss is the main treatment for fatty liver, and GLP-1 reliably delivers it, often improving liver enzymes within a few months.
Many people feel more energetic as weight, sleep and blood sugar improve, though intake-related dips can happen early. Adequate protein and iron help.
Step down to a maintenance dose rather than stopping, and keep the habits — protein, strength training, sleep and steps — that got you there.
Often the first week of each new dose brings the most side effects, then it settles. Slow titration is designed to keep even these manageable.
Rarely on its own, because it acts in a glucose-dependent way. The risk rises mainly if you also take insulin or sulfonylureas — non-diabetics seldom get true lows.
